Understanding how bacteria remember and respond to infections
Molecular mechanisms of memory formation and tolerance in CRISPR-Cas systems
This study is exploring how some tiny organisms, like bacteria, protect themselves from viruses using a special system called CRISPR, and it's especially looking at a less common type to understand how they remember past invaders and fight them off better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11288371 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms behind how certain bacteria and archaea develop immunity against viruses and plasmids using CRISPR-Cas systems. It focuses on a specific type of CRISPR system, known as type III-A, which is less studied compared to others. The researchers aim to uncover how these organisms acquire genetic memories from invaders and how this process influences their immune responses. By analyzing the genetic sequences involved, the study seeks to provide insights into the fundamental workings of bacterial immunity.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated using CRISPR technology, such as genetic disorders or certain types of cancer.
Not a fit: Patients with conditions unrelated to genetic modifications or those not involving bacterial infections may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to advancements in genetic engineering and therapies that utilize CRISPR technology for treating various diseases.
How similar studies have performed: Other research has shown promising results in understanding CRISPR systems, but the specific focus on type III-A systems is relatively novel and less explored.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Aviram, Naama — Sloan-Kettering Inst Can Research
- Study coordinator: Aviram, Naama
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.